TYPICAL: a biotech complete late stage trials and submits a NDA.
ATYPICAL: endless mice studies
ATYPICAL: completing a P2 trial but never starting a P3 trial.
ATYPICAL: hyping a vaccine for ebola but never starting a trial
ATYPICAL: peddling a technology that failed decades ago instead of writing it off.
$200.00 to $6.45 and two reverse splits is an unmitigated disaster.
Place you orders on the Australian Exchange and pick up shares for pennies.
Why pay $6.46 for the penny stock here?
What is ISR?
It's just common sense.
You sound like you fell for the boiler room hype and got conned into a bag.
In few weeks from now, you will wish that your were scared out of your shares, like GENE's unnecessary test scares women.
OK, you are warned that you might develop cancer.
What will you do?
And then, what will you do for the created anxiety?
What is the purpose of the test? To give patients anxiety?
OK, your momma takes the test and it shows that she has a predisposition to develop breast cancer.
How does that help her?
Will she go for chemo to treat a cancer that hasn't developed?
The only practical use of the test might be: the women who are identified by the test that they won't develop cancer won't have to take annual mammograms.
More than 1.2 BILLION shares outstanding is a low number?
Issuing shares at .015 is the low number.
DNA test results because it was found to only cause anxiety.
OK, let's say that your momma's test shows that she will develop breast cancer.
How do you treat it? Have her take chemo before it develops?
The GENE test only gives patients anxiety.
after the exercise of 2,000,000 more options at .015